A. Koczulla (Marburg, Germany), R. G. Wiewrodt (Muenster, Germany)
Mining common pathway deregulation profiles in lung diseases A. Arakelyan, L. Nersisyan, H. Wirth, H. Binder (Yerevan, Armenia; Leipzig, Germany)
| |
Compartment-specific overexpression of glutathione peroxidases during lung fibrosis C. Staab-Weijnitz, I. Fernandez, H. Schiller, K. Heinzelmann, M. Sterclova, M. Vasakova, M. Mann, O. Eickelberg (Munich, Martinsried, Germany; Prague, Czech Republic)
| |
Transposable element LINE1 is activated after exposure to cigarette smoke in primary human lung fibroblasts. N. Miglino, M. Tamm, P. Borger (Basel, Switzerland)
| |
A mechanism for acceleration of GM-CSF autoantibody (GMAb) production in autoimmune pulmonary alveolar proteinosis (aPAP) K. Nakata, T. Tanaka, R. Tazawa (Niigata, Japan)
| |
Genotype-phenotype correlations in patients with primary ciliary dyskinesia with central complex defects related to RSPH1, RSPH4A or RSPH9 mutations B. Prévost, N. Nathan, A. Tamalet, S. Blanchon, G. Montantin, J. F. Papon, E. Kott, L. Bassinet, N. Beydon, N. Collot, B. Copin, F. Dastot, P. Duquesnoy, R. Epaud, I. Honoré, V. Houdouin, S. Tissier, G. Thouvenin, L. Jeanson, B. Vallette, J. de Blic, B. Housset, A. Coste, A. Clément, E. Escudier, S. Amselem, M. Legendre (Paris, Créteil, Toulouse, France)
| |
Increased oxidative stress and apoptosis susceptibility in peripheral blood mononuclear cells from aspirin sensitive asthmatics in comparison to aspirin tolerant asthmatics and healthy volunteers R. Pawliczak, D. Kacprzak, J. Wieczfinska, E. Pniewska (Lódz, Poland)
| |
Whole transcriptome analysis in peripheral blood from asthmatic and healthy subjects in the U-BIOPRED study J. Bigler, X. Hu, M. Boedigheimer, A. Rowe, F. Chung, R. Djukanovic, A. Sousa, J. Corfield, I. Adcock, P. Sterk, A. Welcher (Seattle, Thousand Oaks, United States Of America; High Wycombe, London, Southampton, Uxbridge, Nottingham, United Kingdom; Amsterdam, Netherlands)
| |
Circulating desmosine relates to cardiovascular comorbidity, coronary artery calcification score (CACS), systemic inflammation and mortality in patients with COPD R. Rabinovich, B. Millar, K. Wrobel, G. Chaudhury, K. Ranjit, E. Drost, L. Edwards, D. Lomas, S. Rennard, A. Agusti, R. Tal-Singer, J. Vestbo, E. Wouters, E. J. R. Van Beek, J. Murchison, W. MacNee, J. Huang (Edinburgh, Dundee, London, United Kingdom; Pennsylvania, NC, Omaha, United States Of America; Barcelona, Spain; Odense, Denmark; Maastricht, Netherlands)
| |
Comprehensive analysis of the PTEN domains on TGFbeta-induced aberrant cell motility in lung alveolar/epithelial cells by using PTEN constructs with deletion mutants N. Hashimoto, M. Kusunose, D. Aoyama, M. Kimura, Y. Hasegawa (Nagoya, Japan)
| |
Premature aging and skeletal muscle dysfunction in COPD patients: Development of a cell culture model L. Ramzi, C. Gourab, J. McLeish, E. Drost, L. McGlynn, P. Shiels, W. MacNee, R. Rabinovich (Edinburgh, Glasgow, United Kingdom)
| |
Microarray analysis of long non-coding RNAs in COPD X. Yao, H. Bi, J. Zhou, M. Huang, I. Adcock, P. Barnes (Nanjing, China; London, United Kingdom)
| |
Altered lung developmental pathways during the phase of alveogenesis in mice lacking superoxide dismutase 3, extracellular (SOD3) K. Ganguly, T. M. Martin, V. J. Concel, L. George, A. Mitra, T. A. Thimraj, L. J. Vuga, C. Fattman, N. Kaminski, G. D. Leikauf (Chennai, India; Pittsburgh, New Haven, United States Of America)
| |
Telomere attrition in circulating white blood cells in COPD relates to lung function and outcomes R. Rabinovich, G. Choudhuri, R. Lakhdar, E. Drost, L. McGlynn, J. Bai, P. Shiels, B. Millar, R. Tal-Singer, A. Agusti, W. MacNee (Edinburgh, Glasgow, United Kingdom; Pennsylvania, United States Of America; Barcelona, Spain)
| |
Expression analysis of different alpha-1 antitrypsin transcripts by quantitative PCR B. Martínez-Delgado, I. Vázquez, L. Pérez, B. Lara (Madrid, Spain)
| |
The incidence of severe alpha-1-antitrypsin (AAT) deficiency alleles in COPD patients – Update from Central Eastern European (CEE) AAT Network J. Chorostowska-Wynimko, A. Kubincova, N. Yanev, R. Ulmeanu, R. Struniawski, P. Pobeha, N. Kyuchukov, O. Deleanu, B. Poplawska-Wisniewska, R. Tkacova, Y. Ivanov, F. Mihaltan, A. Valiulis (Warsaw, Poland; Kosice, Slovakia; Pleven, Bulgaria; Bucharest, Romania; Vilnius, Lithuania)
| |
The incidence of alpha-1-antitrypsin (A1AT) deficiency alleles in Polish population - results from large scale newborn screening J. Chorostowska-Wynimko, R. Struniawski, B. Poplawska-Wisniewska, M. Borszewska-Kornacka (Warsaw, Poland)
| |
Identification and distribution of rare and new mutations of Alpha-1-antitrypsin in Germany C. Herr, T. Greulich, R. Koczulla, V. Kotke, C. Vogelmeier, R. Bals (Homburg, Marburg, Germany)
| |
Circulating microRNAs as potential biomarkers in alpha-1 antitrypsin deficiency patients F. Dasi, S. Pastor, M. Mata, M. Amor, E. Serna, S. Castillo, F. Sanz, P. Codoñer-Franch, A. Escribano (Valencia, Spain)
| |